Fineall Pharmaceuticals Private Limited
About Fineall Pharmaceuticals Private Limited
Data last updated:
Fineall Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 10 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2014PTC271432. Its GSTIN is 10AACCF4456G1Z2 (Bihar). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohd Mahboob Alam and Mohammed Saquib Reza.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 277 Third Floor Front Side Shaheen Bagh Abul Fazal Enclave Part – I, I, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2025, the company reported a revenue of ₹47 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹77,738 (net margin 1.7%) and EBITDA of ₹77,738 (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 19% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Fineall Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 277 Third Floor Front Side Shaheen Bagh Abul Fazal Enclave Part – I, I, New Delhi, Delhi, India – 110025
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Fineall Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fineall Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Fineall Pharmaceuticals Private Limited, buy the company report.
Financials of Fineall Pharmaceuticals Private Limited
FY 2025 filings availableFineall Pharmaceuticals Private Limited reported revenue of ₹47 Lakh (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 19%. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹77,738 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹77,738 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fineall Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fineall Pharmaceuticals Private Limited
Fineall Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohd Mahboob Alam | Director | 10 Sep 2014 | 12 Years 1 Months | Current |
| Mohammed Saquib Reza | Director | 10 Sep 2014 | 12 Years 1 Months | Current |
| Mohammad Sadique Hussain | Director | 10 Sep 2014 | 12 Years 1 Months | Current |
| Mohammad Minhajul Haque | Director | 10 Sep 2014 | 12 Years 1 Months | Current |
Auditor
Fineall Pharmaceuticals Private Limited is audited by PRAMOD K. SHARMA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRAMOD K. SHARMA & CO. | FY 2017 | 007857C |
Shareholding
The shareholding of Fineall Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Fineall Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Fineall Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fineall Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fineall Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AACCF4456G1Z2 | Bihar | Active | 26 Jun 2021 |
To see the full GST registrations and return filing status of Fineall Pharmaceuticals Private Limited, buy the company report.
Recent activity
Fineall Pharmaceuticals Private Limited has 4 board changes on record since 2014: 4 appointments. The latest: Mohammad Minhajul Haque was appointed as Director on 10 Sep 2014.
Frequently asked questions
Fineall Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in retail trading, within the trading industry. It was incorporated on 10 September 2014 (12+ years old) and is registered under CIN U85100DL2014PTC271432.
Fineall Pharmaceuticals has 4 current directors:
- Mohd Mahboob Alam - Director
- Mohammed Saquib Reza - Director
- Mohammad Sadique Hussain - Director
- Mohammad Minhajul Haque - Director
The latest financial statements of Fineall Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Fineall Pharmaceuticals is 10AACCF4456G1Z2, registered in Bihar. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Fineall Pharmaceuticals is U85100DL2014PTC271432. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fineall Pharmaceuticals was incorporated on 10 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
Mohammad Minhajul Haque was appointed as Director on 10 Sep 2014. Mohammad Sadique Hussain was appointed as Director on 10 Sep 2014. Mohammed Saquib Reza was appointed as Director on 10 Sep 2014. Fineall Pharmaceuticals has 4 board changes on record in total.
The registered office of Fineall Pharmaceuticals is at C – 277 Third Floor Front Side Shaheen Bagh Abul Fazal Enclave Part – I, I, New Delhi, Delhi, India – 110025.
Fineall Pharmaceuticals operates in the trading industry, in the retail trading segment.
The compliance status of Fineall Pharmaceuticals is compliant as of 30 August 2026. The company is actively filing with the Registrar of Companies.